CRO Quanticate invests in India, boosts workforce
The contract research organisation (CRO) said the site will enable it to expand management, analysis, clinical trial data reporting and post-marketing surveillance capabilities in Asia and further afield.
According to the head of Indian operations Praveen Dass, the office was built in response to increased market demand in India.
“By expanding our presence in India, we are able to increase our capacity, meaning we can cater for more clients on a larger scale,” he said.
New jobs
Quanticate employs more than 280 workers, and has announced plans to increase headcount in the near future.
“We have an ambitious growth strategy to delivery over the next five years, which aims to employ over 60 new members of staff in the coming months,” said Dass.
The company is currently advertising 14 Bangalore-based positions.
Quanticate
Quanticate was formed from a 2007 merger between Statwood and Oxford Pharmaceutical Sciences (OPS), and is headquartered in Hertfordshire, UK and North Carolina, US.
The CRO offers services in biostatistics, statistical programming, clinical data management, medical writing, pharmacovigilance and statistical monitoring.
The company has other locations in Manchester and Edinburgh, UK, Warsaw, Poland and Bloemfontein, South Africa.
